Literature DB >> 23801564

Triple-addition assay protocols for detecting and characterizing modulators of seven-transmembrane receptors.

C David Weaver1.   

Abstract

The detection and characterization of seven-transmembrane-receptor modulators (orthosteric binding site agonists, antagonists, and more recently allosteric modulators) is an area of intense interest for both drug discovery and basic research. Traditionally, assays used to detect and characterize these different modes of modulation have been executed as separate, discrete protocols focused on a particular mode of action (e.g., agonism). In recent years, investigators have begun to combine aspects of these separate protocols to produce methods that detect multiple modes of modulation simultaneously. The power of such approaches is revealed not only in conservation of time and resources, but more importantly in a superior ability to discover and characterize novel modulators of the targets of interest. The protocols in this article describe a general procedure for developing, validating, and utilizing triple-addition assays to enable the simultaneous detection and characterization of multiple modes of seven-transmembrane-receptor modulation. Curr. Protoc. Chem. Biol. 3:119-140
© 2011 by John Wiley & Sons, Inc.

Keywords:  G‐protein‐coupled receptor; agonist; allosteric; antagonist; fluorescence; high‐throughput screening; potentiator; seven‐transmembrane receptor

Year:  2011        PMID: 23801564     DOI: 10.1002/9780470559277.ch110060

Source DB:  PubMed          Journal:  Curr Protoc Chem Biol        ISSN: 2160-4762


  2 in total

Review 1.  Approaches for probing allosteric interactions at 7 transmembrane spanning receptors.

Authors:  Michael T Klein; Paige N Vinson; Colleen M Niswender
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

2.  Discovery and characterization of 2-(cyclopropanesulfonamido)-N-(2-ethoxyphenyl)benzamide, ML382: a potent and selective positive allosteric modulator of MrgX1.

Authors:  Wandong Wen; Yan Wang; Zhe Li; Pang-Yen Tseng; Owen B McManus; Meng Wu; Min Li; Craig W Lindsley; Xinzhong Dong; Corey R Hopkins
Journal:  ChemMedChem       Date:  2014-09-10       Impact factor: 3.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.